Literature DB >> 6587776

Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia.

S M Albelda, G H Talbot, S L Gerson, W T Miller, P A Cassileth.   

Abstract

The utility and safety of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia have not been examined. The results of 21 bronchoscopic procedures in 19 patients with invasive pulmonary aspergillosis and acute leukemia were reviewed. Analysis was confined to the 16 patients who had histopathologically documented infection on biopsy or at autopsy. Fiberoptic bronchoscopy established or suggested the diagnosis of invasive pulmonary aspergillosis in eight of 16 (50 percent) patients. Transbronchial or bronchial biopsy added only one diagnosis to those obtained by bronchial washing and brushing. Although fiberoptic bronchoscopy was a safe and well-tolerated procedure in our patients with invasive pulmonary aspergillosis and acute leukemia, its success rate was only 50 percent overall, and it appeared to be even less successful when performed early in the course of the disease. Fiberoptic bronchoscopy is a useful first procedure for the evaluation of patients with acute leukemia and possible invasive pulmonary aspergillosis, but a negative result does not exclude aspergillosis. Further diagnostic procedures, including repeated bronchoscopy, or institution of empiric antifungal therapy may be warranted if the clinical suspicion of invasive pulmonary aspergillosis is high.

Entities:  

Mesh:

Year:  1984        PMID: 6587776     DOI: 10.1016/0002-9343(84)90853-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

Review 1.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

2.  Development of a chromosomal DNA probe for the laboratory diagnosis of aspergillosis.

Authors:  M A Gabal
Journal:  Mycopathologia       Date:  1989-05       Impact factor: 2.574

3.  Bronchoalveolar Lavage Fluid Cytology in Culture-Documented Invasive Pulmonary Aspergillosis in Patients with Hematologic Diseases: Analysis of 67 Episodes.

Authors:  A Fernández-Cruz; E Magira; S T Heo; S Evans; J Tarrand; D P Kontoyiannis
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

Review 4.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

5.  Outcome of ICU treatment in invasive aspergillosis.

Authors:  J J Janssen; R J Strack van Schijndel; E H van der Poest Clement; G J Ossenkoppele; L G Thijs; P C Huijgens
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

6.  Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR.

Authors:  S Bretagne; J M Costa; A Marmorat-Khuong; F Poron; C Cordonnier; M Vidaud; J Fleury-Feith
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

7.  Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.

Authors:  V Chazalet; J P Debeaupuis; J Sarfati; J Lortholary; P Ribaud; P Shah; M Cornet; H Vu Thien; E Gluckman; G Brücker; J P Latgé
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Pulmonary fungal infections in patients with hematological malignancies--diagnostic approaches.

Authors:  M von Eiff; M Zühlsdorf; N Roos; M Hesse; R Schulten; J van de Loo
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

9.  An emerging opportunistic infection in HIV patients: a retrospective analysis of 11 cases of pulmonary aspergillosis.

Authors:  M Tumbarello; G Ventura; G Caldarola; G Morace; R Cauda; L Ortona
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

10.  Association therapy as a prognostic factor in deep fungal infection complicating oncohaematological diseases.

Authors:  E Pogliani; E Clini
Journal:  Support Care Cancer       Date:  1994-11       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.